Aprea Therapeutics (APRE) Cash flow

500 Followers

Aprea Therapeutics Cash Flow

APRE's free cash flow for Q4 2025 was $-3.07M. For the 2025 fiscal year, APRE's free cash flow was decreased by $677.76K and operating cash flow was $-3.07M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -12.89M	$ -13.56M	$ -12.18M	$ -25.01M	$ -37.69M
Investing Cash Flow	$ 0.00	$ -15.48K	$ -93.09K	$ 0.00	$ 0.00
Financing Cash Flow	$ 4.64M	$ 14.82M	$ 5.14M	$ 682.97K	$ 1.75M
End Cash Position	$ 14.64M	$ 22.89M	$ 21.65M	$ 28.79M	$ 53.08M
Free Cash Flow	$ -12.89M	$ -13.57M	$ -12.27M	$ -25.01M	$ -37.69M

Currency in USD